−141IDR
−428.46 BIDR
1.14 TIDR
371.73 M
About INDOFARMA TBK
Sector
CEO
Agus Heru Darjono
Headquarters
Bekasi
Website
Employees (FY)
1.18 K
Founded
1918
ISIN
ID1000068406
FIGI
BBG000D7RNM5
PT Indofarma Tbk is engaged in the pharmaceutical and healthcare businesses. It operates through the following segments: Medicine, Medical Devices & Others, Pharmaceutical Engineering, and Strategic Alliances. The Medicine segment includes drug production, marketing, distribution, and sales. The Medical Devices & Others segment refers to products developed by the company in the form of instruments, apparatus, and/or implants; as well as other household healthcare supplies. The Pharmaceutical Engineering segment refers to the Indomach business unit, which manufactures, sells, and maintains machineries for the pharmaceutical industry. The company was founded in 1918 and is headquartered in Bekasi, Indonesia.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of INAF is 176 IDR — it has decreased by 9.74% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange INDOFARMA TBK stocks are traded under the ticker INAF.
INAF stock is 10.80% volatile and has beta coefficient of 2.60. Check out the list of the most volatile stocks — is INDOFARMA TBK there?
Yes, you can track INDOFARMA TBK financials in yearly and quarterly reports right on TradingView.
INAF stock has fallen by 32.31% compared to the previous week, the month change is a 55.56% fall, over the last year INDOFARMA TBK has showed a 74.49% decrease.
INAF net income for the last quarter is −71.35 B IDR, while the quarter before that showed −58.55 B IDR of net income which accounts for −21.87% change. Track more INDOFARMA TBK financial stats to get the full picture.
Today INDOFARMA TBK has the market capitalization of 604.36 B, it has decreased by 18.30% over the last week.
No, INAF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, INAF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INDOFARMA TBK stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 1.18 K employees. See our rating of the largest employees — is INDOFARMA TBK on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INDOFARMA TBK technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INDOFARMA TBK stock shows the strong sell signal. See more of INDOFARMA TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INDOFARMA TBK EBITDA is −460.97 B IDR, and current EBITDA margin is −37.86%. See more stats in INDOFARMA TBK financial statements.